Feasibility of an interdisciplinary primary care-based intervention to improve care transitions for hospitalized patients with substance use disorders: The IntACT pilot randomized controlled trial protocol
8 affiliations
- 1Division of General Internal Medicine, Department of Medicine, University of Utah Health, Salt Lake City, Utah, United States of America
- 2Division of Health System Innovation and Research, Department of Population Health Sciences, University of Utah School of Medicine, Salt Lake City, Utah, United States of America
- 3Institute for Health Research, Kaiser Permanente Colorado, Aurora, Colorado, United States of America
- 4Colorado Permanente Medical Group, Denver, Colorado, United States of America
- 5Division of General Internal Medicine, University of Colorado School of Medicine, AuroraColorado, United States of America
- 6Department of Health Systems Science, Bernard J. Tyson Kaiser Permanente School of Medicine, Pasadena, California, United States of America
- 7Birmingham, Alabama Veterans Affairs Medical Center, Birmingham, Alabama, United States of America
- 8University of Alabama at Birmingham Heersink School of Medicine, Alabama, United States of America
Abstract
Background: Hospitalizations are common among individuals with substance use disorders (SUD) and represent crucial opportunities to engage patients in treatment. Quality efforts to increase SUD treatment access in hospital settings must be paired with interventions that support linkage to follow-up SUD and medical care. However, the best way to support patients with SUD during transitions of care after hospitalization is unknown. Methods: The IntACT pilot study is a single-site randomized controlled trial that aims to assess the feasibility and preliminary effectiveness of a primary care-based Interdisciplinary Addiction Care Transition (IntACT) team. IntACT deploys from a partnering primary care clinic to the hospital to meet patients with SUD while they are admitted, then follows them after discharge for four months to facilitate linkage to and retention in follow-up care. The pilot study will randomize 75 hospitalized patients with SUD to receive IntACT or Usual Care, assessing both implementation and effectiveness outcomes over a six month study period. Primary outcomes include implementation measures (e.g., reach, acceptability, feasibility, and cost) assessed using a mixed methods approach, as well as preliminary measures of effectiveness including successful linkage to follow-up medical and/or SUD care after hospitalization and retention in treatment. Secondary effectiveness measures include time to first post-discharge follow-up visit, substance use patterns, and acute care utilization (e.g., hospital readmissions). The IntACT study will also enroll 20 clinicians from hospital and outpatient settings who interact with IntACT while providing patient care to provide input on intervention feasibility, appropriateness, and acceptability. Study design and procedural elements will also be assessed for feasibility and acceptability. Discussion: Identifying promising interventions to support transitions to follow-up SUD and medical care following hospitalization is imperative to increase SUD treatment access and improve care quality. The IntACT pilot study evaluates the feasibility of a novel, potentially scalable team-based care transition intervention, gathering implementation data from both patients and clinicians who are exposed to the intervention. The results of this pilot study will inform intervention refinement for a future fully-powered clinical trial, as well as other implementation and research efforts supporting care transitions for people with SUD. Trial registration: Clinicaltrials.gov NCT07575373
Related
- Feasibility of a multidimensional interdisciplinary rehabilitation program for people with dementia and their informal primary caregivers - a randomized pilot trial with a caregiver focus.
- Pilot Feasibility Study of a Community Health Worker-delivered Tobacco Cessation Intervention During Pregnancy: The Smoke-Free HOPE Randomized Controlled Trial
- A mechanism-oriented immersive virtual reality intervention for psychological distress and helplessness-related processes in hospitalized older adults: study protocol for a multicenter randomized controlled trial
- Feasibility and Preliminary Effectiveness of a Data-to-Care Intervention for HIV-Positive People Who Inject Drugs in Ukraine: A Pilot Cluster-Randomized Trial
- Resilient Together Dyadic Intervention for Persons With Dementia and Their Partners: Protocol for a Feasibility Randomized Controlled Trial
BibTeX
@article{incze2026feasibility,
title = {{Feasibility of an interdisciplinary primary care-based intervention to improve care transitions for hospitalized patients with substance use disorders: The IntACT pilot randomized controlled trial protocol}},
author = {Michael A. Incze and Ulises Amaton and Justin D. Smith and Molly B. Conroy and Ingrid A. Binswanger and Stefan Kertesz and Valerie M. Vaughn and Adam J. Gordon},
journal = {PLOS One},
year = {2026},
month = sep,
doi = {10.1371/journal.pone.0359281},
url = {https://doi.org/10.1371/journal.pone.0359281},
note = {CC BY 4.0},
}
RIS
TY - JOUR
TI - Feasibility of an interdisciplinary primary care-based intervention to improve care transitions for hospitalized patients with substance use disorders: The IntACT pilot randomized controlled trial protocol
AU - Michael A. Incze
AU - Ulises Amaton
AU - Justin D. Smith
AU - Molly B. Conroy
AU - Ingrid A. Binswanger
AU - Stefan Kertesz
AU - Valerie M. Vaughn
AU - Adam J. Gordon
PY - 2026
DA - 2026/09/24
JO - PLOS One
DO - 10.1371/journal.pone.0359281
UR - https://doi.org/10.1371/journal.pone.0359281
AB - Background: Hospitalizations are common among individuals with substance use disorders (SUD) and represent crucial opportunities to engage patients in treatment. Quality efforts to increase SUD treatment access in hospital settings must be paired with interventions that support linkage to follow-up SUD and medical care. However, the best way to support patients with SUD during transitions of care after hospitalization is unknown. Methods: The IntACT pilot study is a single-site randomized controlled trial that aims to assess the feasibility and preliminary effectiveness of a primary care-based Interdisciplinary Addiction Care Transition (IntACT) team. IntACT deploys from a partnering primary care clinic to the hospital to meet patients with SUD while they are admitted, then follows them after discharge for four months to facilitate linkage to and retention in follow-up care. The pilot study will randomize 75 hospitalized patients with SUD to receive IntACT or Usual Care, assessing both implementation and effectiveness outcomes over a six month study period. Primary outcomes include implementation measures (e.g., reach, acceptability, feasibility, and cost) assessed using a mixed methods approach, as well as preliminary measures of effectiveness including successful linkage to follow-up medical and/or SUD care after hospitalization and retention in treatment. Secondary effectiveness measures include time to first post-discharge follow-up visit, substance use patterns, and acute care utilization (e.g., hospital readmissions). The IntACT study will also enroll 20 clinicians from hospital and outpatient settings who interact with IntACT while providing patient care to provide input on intervention feasibility, appropriateness, and acceptability. Study design and procedural elements will also be assessed for feasibility and acceptability. Discussion: Identifying promising interventions to support transitions to follow-up SUD and medical care following hospitalization is imperative to increase SUD treatment access and improve care quality. The IntACT pilot study evaluates the feasibility of a novel, potentially scalable team-based care transition intervention, gathering implementation data from both patients and clinicians who are exposed to the intervention. The results of this pilot study will inform intervention refinement for a future fully-powered clinical trial, as well as other implementation and research efforts supporting care transitions for people with SUD. Trial registration: Clinicaltrials.gov NCT07575373
SN - 1932-6203
ER -